Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amir Lahouegue"'
Autor:
Charlotte Bellier, Laurence Gladieff, Fanny Le Du, Dominique Berton, Charlotte Bonnard, Delphine Suau, Anne-Céline Richard, Ophélie Brenner, Amir Lahouegue, Gilles Freyer, Anne Floquet, Sophie Frank, Maria Kfoury
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 2, Pp 207-213 (2023)
Abstract Background Olaparib, a poly(ADP-ribose) polymerase inhibitor, was approved by the European Commission in June 2019, following the results of the SOLO-1/GOG 3004 trial as maintenance monotherapy in adult patients with BRCA-mutated epithelial
Externí odkaz:
https://doaj.org/article/3c9b9e59c93c484eb7c9c1cf8bc5d447
Autor:
Antoine, Pariente, Joëlle, Micallef, Amir, Lahouegue, Mathieu, Molimard, Marine, Auffret, Laurent, Chouchana, Bernard, Denis, Jean Luc, Faillie, Aurelie, Grandvuillemin, Louis, Letinier, Evelyne, Pierron, Catherine, Pons, Iris, Pujade, Heather, Rubino, Francesco, Salvo
Publikováno v:
Therapies. 78:131-143
In 2018, the "Ateliers de Giens" (Giens Workshops) devoted a workshop to artificial intelligence (AI) and led its experts to confirm the potential contribution and theoretical benefit of AI in clinical research, pharmacovigilance, and in improving th
Autor:
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, Mathieu Molimard, Marine Auffret, Laurent Chouchana, Bernard Denis, Jean Luc Faillie, Aurelie Grandvuillemin, Louis Letinier, Evelyne Pierron, Catherine Pons, Iris Pujade, Heather Rubino, Francesco Salvo
Publikováno v:
Therapies. 78:115-129
Autor:
Serge Halimi, Bogdan Catargi, Alfred Penfornis, Florence Thomas-Delecourt, Sabine Moinaux, Sébastien Bineau, David Koskas, Amir Lahouegue, Delphine Suau
Publikováno v:
Médecine des Maladies Métaboliques. 16:459-466
Autor:
Jean-Luc Cracowski, Sophie Muller, Isabelle Anglade, Gilles Bonnefond, Béatrice Bouhanick, Sylvain Bouquet, Sandrine Cabut, Pascale Daynès, Bernard Denis, Dorothée Durand, Annie-Pierre Jonville-Béra, Amir Lahouegue, Magali Léo, Joëlle Micallef, Mathieu Molimard, Catherine Penfornis, Valérie Querol-Ferrer
Publikováno v:
Therapie
In the code of public health, misuse is defined as intentional and inappropriate use of a medicine or product, which is not in accordance with the terms of the marketing authorisation or the registration as well as with good practice recommendations.
Autor:
Jean-Luc Cracowski, Sophie Muller, Isabelle Anglade, Gilles Bonnefond, Béatrice Bouhanick, Sylvain Bouquet, Sandrine Cabut, Pascale Daynès, Bernard Denis, Dorothée Durand, Annie-Pierre Jonville-Béra, Amir Lahouegue, Magali Léo, Joëlle Micallef, Mathieu Molimard, Catherine Penfornis, Valérie Querol-Ferrer
Publikováno v:
Therapies. 77:69-78
Autor:
Beverley Balkau, Celine Faure, Amir Lahouegue, Bernard Charbonnel, Alfred Penfornis, Nora Chraibi, Florence Thomas-Delecourt, Bruno Detournay
Publikováno v:
Diabetes Therapy
Introduction Saxagliptin is a potent, reversible inhibitor of dipeptidyl peptidase-4 that is indicated for the treatment of type 2 diabetes. The DIAPAZON study was a multicenter observational study intended to document the effectiveness, safety and p
Autor:
Bernard Charbonnel, Celine Faure, Alfred Penfornis, Amir Lahouegue, Bruno Detournay, Nora Lahrichi, Beverley Balkau, Florence Thomas-Delecourt
Publikováno v:
Diabetes & Metabolism. 43:A106